Curis Inc (CRIS)
16.36
-0.15
(-0.91%)
USD |
NASDAQ |
May 03, 16:00
16.70
+0.34
(+2.08%)
After-Hours: 20:00
Curis Total Liabilities (Quarterly): 57.61M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 57.61M |
September 30, 2023 | 60.38M |
June 30, 2023 | 58.08M |
March 31, 2023 | 57.95M |
December 31, 2022 | 62.30M |
September 30, 2022 | 67.11M |
June 30, 2022 | 66.79M |
March 31, 2022 | 64.76M |
December 31, 2021 | 71.59M |
September 30, 2021 | 69.18M |
June 30, 2021 | 68.72M |
March 31, 2021 | 68.68M |
December 31, 2020 | 73.69M |
September 30, 2020 | 74.32M |
June 30, 2020 | 75.33M |
March 31, 2020 | 66.98M |
December 31, 2019 | 69.02M |
September 30, 2019 | 68.26M |
June 30, 2019 | 68.51M |
March 31, 2019 | 69.18M |
December 31, 2018 | 41.86M |
September 30, 2018 | 43.48M |
June 30, 2018 | 46.08M |
March 31, 2018 | 46.91M |
December 31, 2017 | 49.80M |
Date | Value |
---|---|
September 30, 2017 | 51.92M |
June 30, 2017 | 54.57M |
March 31, 2017 | 52.29M |
December 31, 2016 | 28.49M |
September 30, 2016 | 28.32M |
June 30, 2016 | 27.92M |
March 31, 2016 | 29.38M |
December 31, 2015 | 30.46M |
September 30, 2015 | 30.12M |
June 30, 2015 | 31.00M |
March 31, 2015 | 31.69M |
December 31, 2014 | 32.83M |
September 30, 2014 | 33.56M |
June 30, 2014 | 34.49M |
March 31, 2014 | 34.83M |
December 31, 2013 | 35.42M |
September 30, 2013 | 36.97M |
June 30, 2013 | 35.45M |
March 31, 2013 | 34.84M |
December 31, 2012 | 35.50M |
September 30, 2012 | 6.859M |
June 30, 2012 | 7.975M |
March 31, 2012 | 7.747M |
December 31, 2011 | 8.304M |
September 30, 2011 | 6.461M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
57.61M
Minimum
Dec 2023
75.33M
Maximum
Jun 2020
66.80M
Average
68.26M
Median
Sep 2019
Total Liabilities (Quarterly) Benchmarks
AIM ImmunoTech Inc | 9.147M |
Perspective Therapeutics Inc | 22.71M |
Protalix BioTherapeutics Inc | 50.86M |
Electromed Inc | 6.622M |
Armata Pharmaceuticals Inc | 130.43M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 77.28M |
Shareholders Equity (Quarterly) | 19.67M |
Current Ratio | 4.506 |